Sensex 76,059.77 ▼ -0.43% Nifty 23,767.45 ▼ -0.43% 22k Gold ₹ 13,285/gm Silver ₹ 2,40,000/kg Petrol ₹ 111.21 Diesel ₹ 97.83 LPG ₹ 941.50 Crude Oil $ 96.33 USD ₹ 96.43 Sensex 76,059.77 ▼ -0.43% Nifty 23,767.45 ▼ -0.43% 22k Gold ₹ 13,285/gm Silver ₹ 2,40,000/kg Petrol ₹ 111.21 Diesel ₹ 97.83 LPG ₹ 941.50 Crude Oil $ 96.33 USD ₹ 96.43

Cipla Share Price News

Cipla Q1 Results FY27: Net Profit Slumps 39% to Rs 789 Crore Despite Revenue Growth; Share Price Declines

Cipla Q1 Results FY27: Net Profit Slumps 39% to Rs 789 Crore Despite Revenue Growth; Share Price Declines

Cipla Shares Slip Despite USFDA Nod for Generic Ventolin Inhaler; Should You Buy or Sell This Pharma Stock?

Cipla Shares Slip Despite USFDA Nod for Generic Ventolin Inhaler; Should You Buy or Sell This Pharma Stock?

Cipla Q3 Results: Net Profit Falls 57% to Rs 676 Crore on Lanreotide Production Halt; India Business Grows 10%

Cipla Q3 Results: Net Profit Falls 57% to Rs 676 Crore on Lanreotide Production Halt; India Business Grows 10%

Cipla Share Price Today Down 4%; Pharma Stock Among Top Nifty Losers, After USFDA Flags Lapses At Key Partner

Cipla Share Price Today Down 4%; Pharma Stock Among Top Nifty Losers, After USFDA Flags Lapses At Key Partner

Cipla Q2 Results 2026: Net Profit Rises 3.8% YoY, Revenue Up 7.6% on Strong Global Demand; Share Price Down 4%

Cipla Q2 Results 2026: Net Profit Rises 3.8% YoY, Revenue Up 7.6% on Strong Global Demand; Share Price Down 4%

Cipla Q2 Preview FY2026: Steady Revenue Growth Expected; EBITDA May Decline 4% YoY on Higher R&D Spend

Cipla Q2 Preview FY2026: Steady Revenue Growth Expected; EBITDA May Decline 4% YoY on Higher R&D Spend

Diwali Muhurat Trading 2025: Cipla Hits 52-Week High Ahead of Q2 Results; Pharma Stock Up Nearly 2%

Diwali Muhurat Trading 2025: Cipla Hits 52-Week High Ahead of Q2 Results; Pharma Stock Up Nearly 2%

Cipla Q1 Results: Net Profit Rises 10% to Rs 1,298 Crore, Revenue Grows 4%; Strong Cash Position Reported

Cipla Q1 Results: Net Profit Rises 10% to Rs 1,298 Crore, Revenue Grows 4%; Strong Cash Position Reported

Upcoming Dividend Alert: Pharma Announces 800% Dividend For Shareholders; Should You Buy Before Record Date?

Upcoming Dividend Alert: Pharma Announces 800% Dividend For Shareholders; Should You Buy Before Record Date?

Cipla Shares Fall 5% As Donald Trump Hints At ‘Never Seen Before’ Tariffs On Pharma Sector; Should You Buy?

Cipla Shares Fall 5% As Donald Trump Hints At ‘Never Seen Before’ Tariffs On Pharma Sector; Should You Buy?

Dividend Paying Pharma Stock In Focus After Impressive Q3 Earnings, Cipla's Profit Rises 32% YoY

Dividend Paying Pharma Stock In Focus After Impressive Q3 Earnings, Cipla's Profit Rises 32% YoY

Diwali Top Picks By Motilal Oswal: SBI, M&M, Cipla, Raymond, 4 Other Stocks Are Recommended To Buy

Diwali Top Picks By Motilal Oswal: SBI, M&M, Cipla, Raymond, 4 Other Stocks Are Recommended To Buy

Fundamental Muhurat Trading Picks: Canara Bank, Godrej, Reliance, Cipla, 4 Others Are Attractive To Invest

Fundamental Muhurat Trading Picks: Canara Bank, Godrej, Reliance, Cipla, 4 Others Are Attractive To Invest

Cipla Stock Races Toward 52-Week High On Buzz That Bain, Dr Reddy Plan Joint Bid For Promoter Stake

Cipla Stock Races Toward 52-Week High On Buzz That Bain, Dr Reddy Plan Joint Bid For Promoter Stake

Cipla Shares 12% After Strong Q1 Results; Is This Pharma Stock Attractive To Buy?

Cipla Shares 12% After Strong Q1 Results; Is This Pharma Stock Attractive To Buy?

Notifications

Settings

Clear Notifications

Notifications

Use the toggle to switch on notifications

Block for 8 hours
Block for 12 hours
Block for 24 hours
Don't block

Gender

Select your Gender

Age

Select your Age Range